The University Hospital of North Norway (UNN) and the University of Tromsø (UiT) are now participants in what is described as the world's largest research project on bowel cancer EPoS according to the newspaper iTromsø.
2015
Endoscopic screening for gastrointestinal cancers has been introduced in many countries. Precise estimates of the magnitude of benefits and harms of endoscopic screening for cancer are a prerequisite for informed decision making for or against participation in screening for individuals in the target population.
After one year with preparations, the EPoS (European Polyp Surveillance Trial) trial has started patient recruitment. The EPoS study will include 30,000 patients over the next three years. Aim of the study is to find better surveillance intervals for patients with colorectal polyps.
The Clinical Effectiveness Research Group recently held a course in Medical Publishing hosted by the University of Bari in Italy. The course was a great success and the participants were satisfied with both the execution and the content of the course.